2,4-Dienoyl-CoA reductase 1 (DECR1) can limit the rate of PUFA oxidation, and its expression is significantly increased in prostate tumors and castration-resistant mice, but the opposite is observed in breast cancer [76, 77]. Here, DECR1 is linked to breast cancer.